These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28626822)

  • 1. A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis.
    Lashay A; Mirshahi A; Parandin N; Riazi Esfahani H; Mazloumi M; Reza Lashay M; Johari MK; Ashrafi E
    J Curr Ophthalmol; 2017 Jun; 29(2):120-125. PubMed ID: 28626822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial.
    Felix JP; Lira RP; Zacchia RS; Toribio JM; Nascimento MA; Arieta CE
    Am J Ophthalmol; 2014 Apr; 157(4):762-766.e1. PubMed ID: 24388839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foveal reorganization after treatment of acute foveal toxoplasmic retinochoroiditis.
    Abrishami M; Hosseini SM; Momtahen S; Zamani G
    J Ophthalmic Inflamm Infect; 2021 Jun; 11(1):18. PubMed ID: 34151385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
    Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
    Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.
    Silveira C; Belfort R; Muccioli C; Holland GN; Victora CG; Horta BL; Yu F; Nussenblatt RB
    Am J Ophthalmol; 2002 Jul; 134(1):41-6. PubMed ID: 12095806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
    Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
    Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
    Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
    Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim/Sulfamethoxazole and azithromycin combination therapy for ocular toxoplasmosis.
    Yazici A; Ozdal PC; Taskintuna I; Kavuncu S; Koklu G
    Ocul Immunol Inflamm; 2009; 17(4):289-91. PubMed ID: 19657985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pattern of toxoplasmic retinochoroiditis in a Spanish referral center.
    Rey A; Llorenç V; Pelegrín L; Mesquida M; Molins B; Rios J; Arévalo JF; Adán A
    Ophthalmologica; 2013; 229(3):173-8. PubMed ID: 23548496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eccentric fixation patterns, clinical findings, and reading speed in patients with bilateral toxoplasmic macular retinochoroiditis.
    Antunes-Foschini RMS; Ho W; Messias A
    Arq Bras Oftalmol; 2018; 81(5):401-407. PubMed ID: 30208142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.
    Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
    Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse toxoplasmic retinochoroiditis as the initial manifestation of acquired immunodeficiency syndrome.
    Lee YF; Chen SJ; Chung YM; Liu JH; Wong WW
    J Formos Med Assoc; 2000 Mar; 99(3):219-23. PubMed ID: 10820954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.
    Stanford MR; See SE; Jones LV; Gilbert RE
    Ophthalmology; 2003 May; 110(5):926-31; quiz 931-2. PubMed ID: 12750091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.
    Opremcak EM; Scales DK; Sharpe MR
    Ophthalmology; 1992 Jun; 99(6):920-5. PubMed ID: 1630782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute choroidal ischemia associated with toxoplasmic retinochoroiditis.
    Khairallah M; Yahia SB; Zaouali S; Jenzeri S; Attia S; Messaoud R
    Retina; 2007 Sep; 27(7):947-51. PubMed ID: 17891022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
    J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series.
    Kianersi F; Naderi Beni A; Naderi Beni Z; Ghanbari H
    Semin Ophthalmol; 2015 May; 30(3):181-7. PubMed ID: 24175641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.